The Dr. Gabrielle Lyon Show

Episode: The Truth About Hormones: Why Every Woman Should Consider Menopause Therapy

Release Date: September 9, 2025
Host: Dr. Gabrielle Lyon
Guest/Co-Host: Nick (implied, not fully introduced in provided transcript)

Overview

This episode offers a frank, science-based discussion on women's hormone health, focusing on menopause and perimenopause. Dr. Gabrielle Lyon and her guest break down misconceptions about hormone replacement therapy (HRT), outline the risks of outdated research, explain strategies for hormone management, and urge women to actively participate in their health decisions. The show advocates for informed, empowered conversations with healthcare providers, emphasizing that all women will experience menopause and thus must be equipped with up-to-date knowledge and actionable advice.

Key Discussion Points and Insights

1. Why Hormone Therapy Matters for Women

• Universal Impact: Every woman will go through menopause, but most receive inadequate treatment due to old studies and persistent myths. This is in direct contrast to men, many of whom are treated for low testosterone even though not all experience it. [00:03]
• Dramatic Drop in HRT Usage: Since the 2002 Women's Health Initiative (WHI) study, hormone therapy in women dropped 30%, from 26.9% to 4.7%. [02:35]/[02:39]
• Quote:
  “The Women's Health Initiative did more damage to women's health and hormones than any other single study in history.”
  — Dr. Lyon’s Guest [00:08]

2. Common Symptoms of Menopause and Hormone Deficiency

• Core symptoms: Hot flashes, joint pain (including frozen shoulder), brain fog, sleep disturbance, mood changes, and changes in blood lipids are commonly linked to low estrogen. [01:28-02:56]
• Underrecognized Symptoms: Musculoskeletal pain and sexual dysfunction often misattributed to aging or overtraining, rather than hormonal shifts. [02:16]

3. Flaws in the Women's Health Initiative (WHI) Study

• Wrong Medications Studied: WHI used Prempro (synthetic estrogen and progestin), not the bioidentical estradiol and micronized progesterone advocated today. [03:48]
• Misinformation Fallout: Mass hysteria and fear of cancer and blood clots led to HRT’s sharp decline, with millions of women suffering needlessly from untreated menopause symptoms of osteoporosis, dementia, and more. [02:56-04:59]
• Quote:
  "The average age of enrollment, by the way, for the Women's Health Initiative was 63. That's 12 years past normal menopause."
  — Dr. Lyon’s Guest [04:41]

4. Testing and Diagnosis

• Proper Assessment: Holistic hormone panels include estradiol, total estrogen, progesterone, FSH, LH, total and free testosterone, sex hormone binding globulin (SHBG), and DHEA. It's essential for providers to test these for accurate understanding and management. [05:38/07:18/27:34]
• Blood Work Frequency: Baseline, then at 4-6 weeks after starting therapy, and again at 3-4 months. Adjustments should prioritize symptom improvement over strict lab values. [40:43]

5. HRT Delivery Methods and Practical Tips

• Estrogen: Transdermal patch preferred for most; oral and injectable routes also discussed. Absorption and compatibility are individual—patches may not stick in hot climates or with excessive swimming. [10:09-10:39]
• Progesterone: Micronized oral progesterone for sleep, especially in perimenopause or with sleep issues. Creams not preferred due to inconsistent absorption. [19:27-20:56]
• Testosterone: Often started as subcutaneous or intramuscular injection at 1/10 male dose (5-10mg/week typical). No FDA-approved products for women; typically used off-label. [15:29/41:54]
• Vaginal therapy: All women should use vaginal estradiol cream, possibly with testosterone or DHEA, to prevent atrophy, UTIs, and improve vaginal flora. Compounded formulations are often necessary. [22:32/23:03]

6. Role and Stigma of Testosterone for Women

• Benefits: Enhances sex drive, muscle mass, and recovery. Indications are broader than just hypoactive sexual desire disorder (main official use).
• Misconceptions: Fear of side effects (acne, hair loss, voice changes) mostly unfounded with proper dosing and monitoring. [14:40-15:15]
• Quote:
  “There is no FDA-approved testosterone for women... I was shocked at how little data is out there.”
  — Dr. Lyon’s Guest [13:13/13:46/13:51]

7. Lifestyle & Non-Hormonal Factors

• Importance of Muscle Mass: Skeletal muscle mass, diet, and physical activity can mitigate some symptoms and are especially important in conditions like PCOS (polycystic ovarian syndrome).
• Supplements: DHEA useful, especially for libido or vaginal atrophy (e.g., Intrarosa, an FDA-approved insert for painful sex in postmenopausal women). No “hormone balancing” foods or supplements are legitimate substitutes for replacement in deficiency. [26:27]

8. Navigating the Medical System and Advocacy

• Finding a Provider: Women are encouraged to find proactive, menopause-literate clinicians, especially if dismissed or told “you’re fine” despite disruptive symptoms. Immediate provider change often recommended. [30:13-30:19/32:14]
• Professional Organizations: NAMS (North American Menopause Society), Endocrine Society, and ACOG provide directories of trained specialists. [33:54]
• Quote:
  “Part of being a physician… it's a team sport. If someone is coming in and saying, ‘Hey, I'm not feeling well,’ you need to listen.”
  — Dr. Lyon’s Guest [30:16]

9. Risks and Monitoring

• Risks: Must weigh risk of breast/uterine cancer, blood clots (mostly oral forms), genetics, and personal factors. Transdermal (patch) estrogen much safer with respect to coagulopathy than oral. [43:51-45:03]
• Routine Screening: Mammograms, uterine ultrasounds, and comprehensive risk assessments are part of best practices, alongside regular hormone labs and symptom tracking. [45:03]

10. Addressing Myths and Future Directions

• No “Cure,” Only Management: Menopause cannot be prevented, but symptoms can be greatly alleviated with timely and appropriate hormone therapy—"waiting" is often unnecessary, as symptoms do not resolve on their own. [08:55/34:40/35:03]
• Preventive Framing: Early intervention supports bone, cardiovascular, cognitive, and sexual health. Waiting for “disease state” can leave women unnecessarily vulnerable. [32:56]
• Quote:
  “If you treat these things early with velocity, then your chances of living a long healthy life...increases.”
  — Dr. Lyon’s Guest [32:56]

Notable Quotes & Memorable Moments with Timestamps

• “All women should have vaginal estrogen. And when they are entering perimenopause, vaginal estrogen with also testosterone will prevent vaginal atrophy.” — Dr. Lyon’s Guest [00:45]
• “I was shocked at how little data is out there [on testosterone for women]. We’re working on a safety profile study to really help move the needle for people.” — Dr. Lyon’s Guest [13:51-14:00]
• “Not all men will suffer from low testosterone. All women will go through menopause.” — Dr. Lyon’s Guest [06:27]
• “For a woman going on testosterone, I think it’s really important to manage expectations. We typically don’t see a change in body composition if that’s all you’re doing... as opposed to, say, a male.” — Dr. Lyon’s Guest [17:36-18:13]
• "Estrogen therapy is very safe... Menopause hormone therapy considerably lowers risk of hip fractures." — Dr. Lyon’s Guest [37:17]
• “Only 1.8% of women over 40 are using hormone therapy for menopause, even though 100% will go through menopause.” — Dr. Lyon’s Guest [38:16]
• “If a provider immediately shuts you down, go find another provider—immediately.” — Dr. Lyon’s Guest [30:13-30:15]
• “There’s a lot of information that’s taking a long time to get up. Women are not nearly as studied as they should be. It’s embarrassing.” — Dr. Lyon’s Guest [31:07]

Key Segment Timestamps

• Intro to why men get more treatment than women: [00:00–00:39]
• Symptoms of low estrogen: [01:22–02:56]
• Impact and myth of WHI study: [02:35–05:19]
• Hormone testing and assessment recommendations: [05:29–07:53]
• Birth control’s impact on hormones: [07:18–08:46]
• Natural vs. medical menopause solutions: [08:46–10:24]
• Preferred HRT delivery systems: [10:23–12:38]; revisit [41:53–43:14]
• Testosterone for women; rationale, dosing, stigma: [13:07–16:56]
• Body composition and menopause: [17:15–19:22]
• Progesterone for perimenopause & postpartum depression: [19:27–20:56]
• Vaginal hormones and compounded creams: [22:32–23:03]
• Women’s advocacy and finding the right doctor: [30:13–33:54]
• Addressing risks, screening, and delivery methods: [43:51–45:24]

Conclusion

The podcast calls for a radical rethinking of menopause treatment—insisting that the vast majority of women are left suffering due to outdated medical beliefs and unnecessary fear. Rather than wait for symptoms to worsen, women should seek proactive care, understand their options, and demand engagement from their providers. Combined with lifestyle changes, the right hormone strategies can dramatically reshape health, vitality, and wellbeing across every phase of womanhood.

Dr. Lyon and her guest make clear: being informed, assertive, and open to change is necessary for every woman facing menopause or perimenopause, and the medical community is (slowly) catching up to these needs.

For further resources:

• North American Menopause Society (NAMS)
• Endocrine Society
• American College of Obstetricians and Gynecologists (ACOG)
• Dr. Lyon’s practice: Strong Medical

Note: This summary omits ads, sponsor segments, and non-content material to provide the most direct, actionable insights from this episode.